
NIQS DELIVERS NON-INVASIVE GLUCOSE MONITORING WITH 99.3% ACCURACY
NIQS Tech has produced class-leading accuracies in optical-based non-invasive glucose monitoring, including 97.5% clinical accuracy and 99.3% clinical acceptability.

NIQS named as Leading Innovator in Diabetes Management
NIQS named as Leading Innovator in Diabetes Management 2025

Dr. Ioanna Pallikara Joins NIQS Tech
Dr. Ioanna Pallikara joins NIQS as Lead Data Scientist

NIQS in Top 15 the Diabetes Center Berne Open Innovation Challenge
NIQS in the Top 15 of the 2025 DCB Open Innovation Challenge


NIQS Tech selected as One to Watch in 2024 by Yorkshire Tech Climbers
NIQS Tech selected as one to watch in 2024 by Yorkshire Tech Climbers

NIQS selected as a runner up in IOP qBIG Prize 2024
NIQS selected as a runner up in IOP qBIG Prize 2024

NIQS Tech selected as a finalist in EISA’s awards
NIQS selected as a finalist in the EISA’s awards

NIQS highlighted by Health Innovation Leeds
NIQS Tech highlighted by Health Innovation Leeds in their overview of the vibrant healthcare and medical technology ecosystem that is being cultivated in Leeds and the wider West Yorkshire region.

NIQS shortlisted for 2x Start-Up Awards for 2024
NIQS shortlisted for 2x Start-Up Awards for 2024

NIQS invited to meet with Louis Taylor, CEO of the British Business Bank
NIQS invited to meet with Louis Taylor, CEO of the British Business Bank

One million have undiagnosed type 2 diabetes in England
Did you know that a staggering one million people in the UK are potentially living with undiagnosed Type 2 diabetes?
Data from the Office for National Statistics shows that around one million of us are living with Type 2 diabetes but are completely unaware of it, which unfortunately puts our health at risk.

Health Innovation Leeds highlights NIQS in a spotlight on spin-outs
Spotlight on spin-outs!
From the science lab to the boardroom #Leeds is one of the top academic hubs for #spinout company creation in the UK.
Racial bias in technology
In a world driven by innovation, it is crucial to ensure that technology serves everyone equally. Sadly, this is not always the case and is evidenced by the so-called “racial bias”, which has seen sensor technologies impacting individuals with darker skin tones.

Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years
Research from Cambridge University - supported by by the Medical Research Council, British Heart Foundation, Health Data Research UK and NIHR Cambridge Biomedical Research Centre - suggests an individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years.
NIQS recruits photonics engineer intern - Gina Benni
NIQS recruits Gina Benni as photonics engineer intern

Prospect Magazine interviews Royal Society of Chemistry winner, NIQS
Prospect Magazine interviews NIQS on winning this year’s RSC Emerging Technologies competition

Prospect Magazine - The Royal Society of Chemistry Emerging Technologies winners
Prospect Magazine presents the winners of the Royal Society of Chemistry Emerging Technologies Competition for 2023

NIQS wins Royal Society of Chemistry Emerging Technologies competition
NIQS wins the Royal Society of Chemistry Emerging Technologies competition

NIQS selected as a one-to-watch in Yorkshire Tech Climbers 2023
NIQS selected as a one-to-watch in Yorkshire Tech Climbers 2023